ABSTRACT
T he olfactory epithelium (OE) is a pseudostratified columnar epithelium specialized for transducing the sense of smell. Studies of the physiology and pathophysiology of the OE have been spurred by the frequency of clinical disorders of olfaction and associated disorders of gustation l for which no treatment is currently available, and by the ability of this tissue to replace its sensory neurons (olfactory receptor neurons), at a low level under normal conditions 2 . 3 and on a much larger scale following injury.4--11
The OE contains three main types of histologically identifiable cells: basal cells, olfactory receptor neurons (ORNs), and supporting (or sustentacular) cells. 12Another cell type that has been described, the microvillar cell, may be a subtype of the receptor neuron. 13More recent studies using molecular markers indicate an even greater cellular complexity of the OE. Basal cells consist of at least three cell types, all of which lie in the basal one-fourth of the OE: (1) the "horizontal" or "dark" basal cells lie directly apposed to the basal lamina of the epithelium, and are distinguished by their expression of keratin intermediate filaments, 14--16 (2) Immediate Neuronal Precursors (INPs), also referred to as "globose" or "light" basal cells, lie above the horizontal basal cells in the basal compartment of the OE. 14 ,15,17INPs, as their name suggests, divide to directly give rise to postmitotic ORNs, 14,15,17but INPs themselves appear to be the progeny of the third type of basal cell, (3) another "globose" basal cell which is distinguished by expression of the transcription factor MASH1. 18 ORNs can be subdivided into two types, based on their expression of molecular markers and their degree of morphological maturity: Immature ORNs express the neural cell adhesion molecule NCAM and the growth-associated protein GAP-43 (B_50).8,9.14.19Mature ORNs retain expression of NCAM, lose expression of GAP-43, and acquire expression of Olfactory Marker Protein (OMP) as they attain a more apical position within the OE, elaborate extensive cilia, and establish stable synaptic contacts with the olfactory bulb. 8,9,14,19,ZO Sustentacular or supporting cells of the OE have their cell bodies located in the apical one-fourth of the OE, and express at least two unique markers: Sus-I, an antigen present on sustentacular and Bowan's gland cells in the rat,ZI and a mucin that can be detected in both rat and mouse using a monoclonal antibody, 3C2?Z These cell types are depicted in the drawing shown in Figure I , An understanding of neuronal homeostasis in the OE, i.e., normal maintenance of neuronal number, requires knowledge of factors that influence survival and death of different cells of the ORN lineage. While much descriptive work exists concerning proliferation, death, and survival of cells of this lineage, the factors that regulate these processes are only beginning to be elucidated. In this review, we explore factors and processes that affect maintenance of neuronal number in normal, adult OE. We draw upon studies of the OE that employ both in vitro (tissue culture) and in vivo (surgical manipulation, immunohistochemistry, etc.) experimental approaches, in both developing and adult animals.
Lumen of nasal cavity
While these experimental studies of the OE have largely used rodents, the results are likely to be directly applicable to man, since the anatomy and physiology of the OE appears to be quite similar among mammals,7,lZ NEURONAL HOMEOSTASIS IN THE OE A t least two major processes affect neuronal number in adult OE: These are neurogenesis (proliferation of neuronal precursors and differentiation into postrnitotic ORNs) and neuronal death. These two processes appear to be interrelated in their regulation, as well as being subject to independent factors. Understanding of neuronal homeostasis in adult OE is facilitated both by knowledge of factors influencing neurogenesis and neuronal death in the OE and by recalling certain aspects of the developmental biology of this tissue, since many of the developmental processes that occur en utero and during early postnatal life persist in adult OE.
Neurogenesis and Neuronal Differentiation
N eurogenesis in adult OE is an ongoing process that serves to replace lost ORNs. In contrast with other neuronal systems in adult animals, the capacity of the OE for continual neurogenesis reflects the persistence into adulthood of some of the characteristics of developing neuronal systems, e.g., proliferative neuronal precursor cells Z , 5,7.9,18,19and he INP, the dIrect precursor of ORNs, itself appears to be the progeny of an earlier neuronal precursor, the MASHI-expressing "globose" basal cell; the MASH I-expressing precursor also appears to function as a transit amplifying cell in the ORN differentiative pathway.18 A self-renewing stem cell, for which no molecular marker yet exists, may give rise to the MASH I-expressing cell, and is thought to underlie the OE's capacity for continual ncurogenesis throughout life. Following their production by INPs, immature postmitotic ORNs mature, a process estimated to take approximately 7 days in vivo based on appearance of OMP expression in ORNs previously labeled with a nuclear labeling agent,34 pathogen-free environment (caged in a laminar flow hood), some ORNs lived for one year, or even longer. 36 This led to the hypothesis that constitutive death of ORNs, i.e., a normal, basal level of cell death, was largely due to failure of immature ORNs to establish synaptic contact with the olfactory bulb, rather than from regular turnover of mature ORNs which were apparently quite long-lived. 36 The hypothesis that immature ORNs die in adult OE, a continually developing neuronal tissue, is consistent with the normal occurrence of extensive neuronal death in the developing nervous system, wherein many more neurons (::=:2-fold) are initially produced than are ultimately left after synaptic connections with targets have been made. 37 This normal developmental death of neurons has been ascribed to limiting amounts of target-derived survival factors (trophic substances or neurotrophic factors), such that many neurons die because they are unable to acquire sufficient amounts of these factors (see reviews by Oppenheim 37 and Barde 38 ). Neurotrophic factors, polypeptide growth factors that support neuronal survival, appear to promote survival by inhibiting an intrinsic genetic program of cell death, known alternatively as programmed cell death or apoptosis (see reviews by Johnson and Deckwerth 39 and Raff et a1. 40 ). Evidence for this includes the ability of inhibitors of transcription and translation to prevent death of growth factordeprived neurons in culture. 39 ,41.42Although a great deal of progress toward identification of the "cell death" genes and their regulation has been made in invertebrates (reviewed in detail by Drisco1l 43 ), such strides are just beginning in vertebrates. It is already apparent, however, that proteins similar to those involved in regulation of apoptosis in invertebrates are also functional in vertebrates. [44] [45] [46] [47] Mammalian cells undergoing apoptosis exhibit characteristic changes: e.g., condensation of chromatin (pyknosis), dissolution of the nucleus, contraction of cell volume, and formation of many small membrane-bound fragments that contain remnants of the nucleus and cytoplasm. 48 These membrane-bound fragments, called apoptotic bodies, eventually break away from the plasma membrane, and are ultimately phagocytosed, either by nearby cells or by macrophages. 49 In addition to characteristic morphologic changes, most cells undergoing apoptosis also undergo fragmentation of their nuclear DNA, a characteristic increasingly exploited as a marker for apoptotic cells since the development of methods for its detection in sitU. 8 ,50-52 The first study to directly quantify cell death in normal OE employed histological techniques to detect cells with nuclear pyknosis, a morphological criterion for cell death. In that study, pyknotic cells were observed in all regions of the OE. 27 More recently, we have used in situ detection of DNA fragmentation (using terminal transferase-mediated dUTP-biotin nick end-labeling or TUNEL 50 to quantify apoptotic cells in normal OE).8 Using DNA fragmentation as a criterion for apoptosis, in combination with immunohistochemistry for cell type-specific markers, we have classified apoptotic cells in adult mouse OE and found that cells at all stages of the neuronal lineage-neuronal precursors, immature ORNs, and mature ORNs-undergo apoptosis in normal, unoperated OE. 8 DNA fragmentation was not observed in horizontal basal cells or sustentacular cells. 8 Thus, there is a constitutive (normal, ongoing) level of apoptosis in all types of cells of the ORN lineage. This constitutive apoptosis occurs only at a low level; however, the number of apoptotic cells in the OE increases by as much as 20-fold following surgical ablation of the olfactory bulb (see below).
An example of in situ detection of DNA fragmentation in combination with cell type-specific immunohistochemistry in adult mouse OE is shown in Figure 3 . As shown in 3D, few cells have fragmented DNA (are TUNEL-positive) in normal, unoperated OE. However, if one olfactory bulb is surgically removed (unilateral olfactory "bulbectomy"), then a striking increase in the number of TUNEL-positive cells is seen in ipsilateral OE as soon as 24 hours postsurgery (Fig. 3A) . The anti-NCAM immunohistochemistry performed on these same sections (Fig. 3B,D) demonstrates that the vast majority of these apoptotic cells are within the neuronal (NCAM-positive) layer of the OE. Others have also observed a dramatic increase in DNA fragmentation in DNA extracted from the OE following bulbectomy. 53 We have used these techniques to quantify the timecourse and extent of apoptosis in different types of cells of the ORN lineage following unilateral bulbectomy in adult mice, and the results of this analysis are shown in Figure 4 . Compared with unoperated OE, all cells in the neuronal lineage of ipsilateral OE undergo a marked increase in DNA fragmentation 24 hours after unilateral bulbectomy. When animals are allowed to survive for long periods, e.g., 2 months, following bulbectomy, DNA fragmentation remains elevated in ipsilateral OE exclusively in mature ORNs. These findings suggest that only mature ORNs are dependent upon the presence of the olfactory bulb for survival, whereas immature ORNs and neuronal precursors apparently do not depend upon the olfactory bulb for survival. It is possible that these cells obtain trophic support from other cell types within the OE, or, in the case of immature ORNs, from ensheathing cells of the olfactory nerve. These results also imply that immature ORNs undergo a developmental change in trophic factor requirements, such that at some point, perhaps coincident with reaching biochemical maturity, they become dependent upon their target tissue. 8 We are currently testing, via administration of exogenous growth factors to mice that have undergone unilateral bulbectomy, whether polypeptide growth factors, e.g., neurotrophins, are able to prevent bulbectomy-induced PCD in neuronal cells of the OE in vivo.
The neurotrophin family of polypeptide growth factors is one class of neurotrophic factor that may regulate neuronal survival in the OE. This idea was suggested by findings that neurotrophins are expressed in the olfactory bulb,54,55 and that appropriate receptors for some of these growth factors are expressed by ORNS. 8 ,56 In vitro experiments indicate Calof et al. 95 that ORNs from embryonic mouse OE undergo PCD, manifested by rapid DNA fragmentation and death, when cultured in the absence of survival factors. 8 In addition, death of these cells in culture is inhibited by pharmacological agents known to inhibit PCD, e.g., aurintricarboxylic acid, cyclic AMP analogs, and inhibitors of transcription and translation. 8 Certain neurotrophins, brain-derived neurotrophic factor,8,3o neurotrophin-3 8 and neurotrophin-5,8 are also able to promote survival of ORNs to some extent in vitro, Whether neurotrophins, or other growth factors, are responsible for mediating neuronal survival in the OE in vivo is not known,
B. C) and contralateral (D, E. F). DNA fragmentation in ipsilateral DE is markedly increased compared to contralateral DE (A, D). Cells with DNA fragmentation appear as brightly fluorescent dots in these photomicrographs of mouse DE, e.g. arrow in (A). Despite the marked difference in DNA fragmentation at 24 hours after target ablation, no obvious difference in NCAM expression (B. E) or in structural integrity of the DE (Nomarski optics; C, F). Reprinted with permission from

Pathological Causes of Neuronal Death in the OE
A variety of factors may cause or contribute to neuronal death in the OE-such factors likely vary depending on the type of cell within the ORN lineage. It is useful to classify these factors with regard to their etiology as extrinsic or intrinsic to the OE. It is also important to emphasize that neuronal cells of the OE are subject to both apoptotic American Journal of Rhinology and non-apoptotic cell death (Le., necrotic cell death), and that neither the magnitude nor the mechanism of death caused by most factors is known. Factors that account for a low, regular level of death may be viewed as contributing to constitutive (normal, ongoing) neuronal death in the OE. Factors that cause death of OE neurons on a much larger scale, then, would be viewed as pathologic. A summary of known and hypothesized factors, extrinsic and intrinsic, that may cause or contribute to constitutive and/or pathological death of cells of the ORN lineage is provided in Table 1 .
Viral upper respiratory illness is associated with pathological damage, e.g., extensive neuronal cell loss, to OE of patients with subsequent anosmia or hyposmia.
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Destruction of neuronal cells of the OE may also result from infection with viruses trophic for these cells, but associated with nonrhinologic primary infection, e.g., herpes simplex encephalitis. 60 It is also possible that viruses may damage the OE in the absence of clinically apparent infection. Bacterial and fungal rhinitis may also cause local tissue destruction that mayor may not spare the OE. To protect 8 against diverse infectious insults, the OE uses various defenses, including both immune (secretory IgA) and nonimmune components (Iactoferrin and lysozyme) secreted into mucus overlying the OE by Bowman's glands. 61 Immune deficiency, e.g. isolated IgA deficiency, as well as poor nutritional status may partially compromise the defense barrier within the mucus of the OE.
As suggested by Mott and Leopold,62 chemical mediators of inflammation associated with various diseases of the nose and paranasal sinuses may also damage ORNs. Because cytokines have been shown to induce apoptotic death of some cultured neurons,63 such a mechanism could conceivably operate to cause death of cells of the ORN lineage as well. Macrophages are a possible source of cytokines in the OE, since they are known to migrate into the OE to phago- cytose cellular remnants and debris following axonal injury.4 Although speculative, the acute upregulation of apoptotic death of immature ORNs and neuronal precursors in ipsilateral OE of mice subjected to unilateral bulbectomy (see Fig. 4 ) may be the result of a local inflammatory response, e.g., effects of substances released by activated macrophages. 8 A humoral response could not account for this unilateral up-regulation of apoptotic death of immature ORNs and neuronal precursors, while direct injury could not account for increased death of neuronal precursors, cells that do not have axons and that are not directly injured by the bulbectomy procedure. 8 Although improvement in olfactory function may occur with administration of systemic corticosteroids to patients with olfactory loss associated with nonobstructive, noninfectious nasal/paranasal sinus disease, e.g., allergic rhinitis,64 neither the effects that inflammatory mediators may exert on the OE nor the mechanism by which they may cause olfactory loss is known. Although eosinophils may release several neurotoxic inflammatory mediators during the late phase allergic response, e.g., eosinophil-derived neurotoxic protein,64 it is unlikely that such factors lead to functionally significant neuronal death in the OE, i.e., death of sufficient ORNs to cause anosmia, since patients with anosmia attributable to allergic rhinitis often experience transient spontaneous improvement in their ability to smell, or rapid regain of normosmia with short courses of systemic steroid therapy. 64 Jafek et a\. and others have noted decreased numbers of ORNs in OE from patients with long-standing post-traumatic anosmia (PTA).59.65-67 In this respect, OE from patients with PTA resembles OE from mice with long-term survival following surgical ablation of the olfactory bulb. Jafek et al. also noted the abnormal finding of large numbers ofaxons within the OE of patients with PTA, and proposed that fibrotic healing of the cribriform plate prevents regenerating axons from reaching the olfactory bulb. 65 The abnormal finding of large numbers ofaxons within the OE of patients with PTA may be explained, however, by phenotypic analysis of cell death in mouse OE acutely following target ablation. The fila olfactoria contain bundles ofaxons, from both mature ORNs (already connected with target glomeruli in the olfactory bulb) and immature ORNs (many not yet having reached the olfactory bulb), that are surrounded by ensheathing cells. Recall that after surgical removal of the olfactory bulb in mice, a reasonable model for acute changes in OE of humans with shearing injuries of the fila o]factoria, all cell types of the ORN lineage undergo a dramatic increase in apoptotic death (see above). If all axons within a group of ensheathing cells degenerate, the physical space previously occupied by these axons is not likely to be maintained, and axons from newly-generated ORNs may be unable to enter.
Various endocrine disorders, e.g., diabetes mellitus,68,69 hypothyroidism,7o. 71 and pseudohypoparathyroidism,62 have been associated with decreased olfactory ability. Of these, hypothyroidism is of particular interest since inducing the hypothyroid state in adult mice leads to a reversible loss of the sense of smell. 72 In adult mice with propylthiouracil-induced hypothyroidism, the majority of new]y-generated ORNs undergo premature death (living >5, but <15 days).73 This indicates that the hypothyroid state interferes with survival of newly-generated ORNs. Since synaptic contact with the olfactory bulb is necessary for prolonged survival of ORNs, 19it may be the case that hypothyroidism interferes with developmental processes necessary for this to occur. Alternatively, it may be that thyroid hormone is itself a survival factor for ORNs.
In the absence of pathogens, local inflammation, trauma and endocrinopathy, death of OE neuronal cells may result from insults of an environmental nature, e.g., exposure to airborne chemicals (not necessarily in high concentrations or for prolonged periods of time). It is known that exposure to a wide variety of chemicals may cause damage to the American Journal of Rhinology OE 74 and variable loss of 0lfaction. 62 That the OE is susceptible to such insults is supported by the finding that when OE is isolated from the environment, precluding exposure to airborne chemicals or pathogens, ORNs live considerably longer than under normal circumstances. 36 Also consistent with the idea that neuronal cells of the OE may be highly susceptible to various airborne chemicals, the sustentacular cells of the OE are known to contain extremely high levels of detoxifying enzymes. 75 Interestingly, levels of one cytochrome P-450 isoform in human OE decline in patients over 60 years of age. 76 Such detoxifying enzymes may be critical for maintaining neuronal cells of the OE, since a sharp decline in odor identification ability also occurs in patients in this age group.77.78 Chemical insults to the OE may also arise, in part, as a result of endogenous metabolism in the OE: several chemicals are known to undergo bioactivation to highly toxic metabolites by detoxification enzymes ]0-cated in the olfactory epithelium, e.g., cytochrome P-450-catalyzed conversion of hexamethylphosphoramide (HMPA) to formaldehyde. 79 Detoxification enzymes other than cytochrome P-450-dependent monoxygenases (phase I biotransformation enzymes), e.g., olfactory UDP glucuronosyl transferase (UGT, a phase II biotransformation enzyme), may also be critical for protecting the OE from toxic chemicals. 8o In mice and rats, the OE appears to be organized, along anteroposterior and cephalocaudal axes, into four discrete zones of odorant receptor expression. 81 . 82 Since the number of odorant receptor genes is estimated to be~1000 in mamma]s,83-86 and since little or no overlap appears to occur in odorant receptor expression between different zones,81,82 each odorant receptor expression zone may contain severa] hundred different odorant receptors. 82 Although ORNs expressing the same odorant receptor appear to be spread out over anteroposterior and cephalocaudal extents of each zone,81.82 these cells appear to innervate relatively few (one to several) glomeruli within the olfactory bu]b. 87 ,88 The existence of odorant receptor expression zones and the specificity with which ORNs appear to converge upon in-dividual glomeruli within the olfactory bulb has been proposed as a potential anatomical basis for spatial patterning of odorant responsiveness in the olfactory system,87.88 an idea also suggested by electrophysiological studies. 89 ,9o If such an organization does indeed exist, it is conceivable that cells failing to reach appropriate target glomeruli or to express appropriate odorant receptors might undergo apoptosis. In support of a role for apoptosis during development and organization of the OE, we have observed substantial numbers of apoptotic neuronal cells, distributed in a bilaterally symmetric pattern, in early postnatal mouse OE (J.D. Holcomb and A.L. Calof, unpublished observation).
Death of neuronal cells of the OE also appears to increase with increasing age. In their analysis of sections of postmortem samples of human OE, Getchell and Getchell noted that apoptotic bodies were present more frequently in fetal, neonatal and old adult subjects than in young to middleaged adult subjects. 91 Increased numbers of apoptotic bodies in OE of old adult subjects correlated with decreased numbers of mature ORNs in these subjects. The cause for this decrease in numbers of mature ORNs in elderly subjects is not known. In part, this may reflect an age-dependent decline in the ability of the OE for self-repair through neurogenesis. 92 Whether age-related replacement of OE with respiratory epithelium that occurs in humans 93 results from discrete areas of the OE becoming senescent, with gradual physiologic loss of both ORNs and the ability to replace them, or from cumulative effects of environmental insults is not known.
CONCLUSIONS
M any factors, both genetic and epigenetic, are potentially involved in maintenance of neuronal homeostasis in mammalian OE. It is clear that all cell types of the neuronal lineage of the OE undergo constitutive death that is characteristic of programmed cell death or apoptosis, and that acute and prolonged target deprivation differentially affect apoptotic death of these cells. To some degree, the constitutive apoptosis of neuronal cells of the OE, and the marked sensitivity of ORNs to removal of their target tissue, may reflect normal developmental phenomena related to proliferation, differentiation, and maturation of neurons of the OE. Other factors, e.g., pathogens, local inflammation, thyroid function, levels of olfactory detoxifying enzymes, bioactivation of various airborne chemicals to highly toxic metabolites, and age, also influence neuronal death in the OE. Tissue culture experiments have been useful for identifying growth factors and pharmacological agents that can at least partially ameliorate neuronal death in the OE. If specific survival factors, or other pharmacological inhibitors of apoptosis, are able to inhibit apoptotic death of cells of the neuronal lineage of the OE in vivo, it will be of interest to determine whether such agents have any therapeutic benefit for specific anosmias in man.
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